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Hepatitis C virus (HCV), a causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, constitutes a serious health problem worldwide (8) . HCV has a positive strand RNA genome that produces at least ten functional viral proteins: core, envelope (E)1, E2, p7, nonstructural protein (NS)2, NS3, NS4A, NS4B, NS5A, and NS5B (9, 10) . NS5B
is an RNA-dependent RNA polymerase, which plays a central role in viral genome replication (11, 12) . HCV genome replication can be evaluated using a HCV subgenomic replicon system, which Lohmann et al. firstly established (13) . In this system, cells carry a HCV subgenome RNA encoding NS3 to NS5B. Using this system, it has been proposed that HCV genome replication occurs in the replication complex (RC), which contains the viral genome RNA and HCV NS proteins. The RC forms on the surface of the intracellular membranes including the endoplasmic reticulum (ER) membrane and is surrounded by a membrane structure (14) (15) (16) (17) . It also has been reported that HCV genome replication associates with the lipid rafts on these intracellular membranes, such as the ER membrane (14, 18 transfection reagent (Roche) as described previously (25) . RNA transfection was achieved using DMrie-C transfection reagent (Invitrogen)
as described previously (21) . siRNA was transfected by using siLentFect (BIORAD) (21) . 
Luciferase assay
A luciferase assay monitoring HCV replication activity was performed as described previously (22, 26) . In Fig. 1A , we used LucNeo#2 cells, stably carrying luciferase-containing subgenomic replicon (22).
In Fig. 2D , 2E, 4C, and 6A, we transiently transduced luciferase-containing replicon LMH14 RNA together with each expression plasmid into cured MH-14 cells (26). A luciferase assay detecting the transcriptional activity driven from the ERE was performed as described previously (25) .
Real time RT-PCR analysis
Real time RT-PCR analysis was performed as previously described (20).
Immunoblot analysis
Immunoblot analysis was performed as previously described ( 
Indirect immunofluorescence analysis
Indirect immunofluorescence analysis was performed as described previously (25) . The 
RT-PCR analysis
RT-PCR analysis was performed as described 
GST pull down assay
GST pull down assay was conducted as described previously (25) .
Immunoprecipitation analysis
Immunoprecipitation analysis was performed as described previously (25) . The antibodies used in this study were mouse normal IgG as a
anti-NS5B (anti-NS5B#10; a generous gift from Dr. Kohara at Tokyo Metropolitan Institute of Medical Science), anti-FLAG, and anti-caveolin2 antibodies.
Fractionation of cell extracts
MH-14 cells transfected with the expression plasmid for FLAG-tagged ESRα were fractionated essentially as described previously (25) .
HCV replication complex assay
Isolation of HCV RC was done as described previously (16, 21) .
In vitro HCV infection experiment
In vitro HCV infection was conducted essentially as described (23) . 
MTT assay
MTT assay was performed to examine the cell viability using Cell proliferation kit II, XTT (Roche) according to the manufacturer's protocol.
Results

Tamoxifen suppressed HCV genome replication
We screened for agents that suppressed HCV genome replication using a HCV subgenomic by guest on http://www.jbc.org/ Downloaded from replicon system (13, 16) . Among compounds tested, we observed that TAM inhibited HCV genome replication. HCV replication activity, monitored by luciferase activity (22) , and the amount of HCV RNA was decreased with TAM treatment in a dose-dependent manner (Fig. 1A and B). The expression of HCV proteins, NS5A
and NS5B, detected by immunoblot (Fig. 1C) and indirect immuofluorescence analyses ( ESRβ did not (Fig. 2D) . ESRα-induced augmentation of the replication was reversed upon TAM treatment (Fig. 2D) . These results suggested a significant role of ESR, especially ESRα, in HCV genome replication.
ESRα(L540Q), carrying a leucine to glutamine point mutation at 540 aa within the LXXLL motif (536-540 aa) of ESRα (37), had much lower transactivation activity driven from ERE (Fig. 2C) . However, ESRα(L540Q) stimulated HCV replication activity approximately 5-fold, although the stimulation was less than that by wild-type ESRα (Fig. 2E) . Thus, ESRα having lower transactivating capacity could still facilitate HCV replication.
ESRα interacted with HCV NS5B
Thus, chemical biology approach revealed the involvement of ESR in HCV genome replication.
Then, we investigated the molecular mechanism and ESRα(258M), in which IRK at 255-257 aa and DRR at 258-260 aa was replaced by TGT and AQT, respectively, had little affinity with NS5B ( Fig. 4A ), but still possessed the ERE-mediated transactivation capacity (Fig. 4B) (Fig. 4D) .
Moreover, ESRα in MM fraction was coprecipitated with NS5B ( Fig. 4E) . It suggests the possibility that the interaction between NS5B and ESRα, at least in part of them, occurs on the ER membrane.
ESRα promoted the participation of NS5B in HCV replication complex
It was reported that HCV proteins involved in the replication machinery was associated with the lipid raft on the ER and cofractionated with CAV2. Coimmunoprecipitation assay showed that NS5B associated with CAV2 (Fig. 5A) . In (Fig. 5D, lanes 1 and 2) , and ER protein calnexin, which did not accumulate in the RC, was digested by treatment with digotinin/protease (Fig. 5D, lanes 2-4) . An ER lipid raft component CAV2 were still detected under the digitonin/protease treatment (the RC-containing fraction) (Fig. 5D, lanes 3 and 4) .
Under this condition, a part of NS5B was detected in the digitonin/protease-resistant fraction as described previously (16) (Fig. 5D,   lanes 3 and 4) . However, NS5B in this fraction was decreased upon treatment with TAM ( by guest on 
